Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lying down or sitting up? study tests best position for bladder cancer drug

NCT ID NCT07474519

Recruiting now Knowledge-focused Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Mar 20, 2026 · Last updated Jun 06, 2026 · Updated 14 times

Summary

This study looks at whether changing a patient's position (lying down, sitting up, or moving freely) during BCG treatment for non-muscle invasive bladder cancer affects how long the medicine stays in the bladder. About 40 adults who have not started this treatment will try each position and have their dwell time measured. The goal is to find ways to help patients who struggle to hold the medicine for the full 2 hours.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

NON-MUSCLE INVASIVE BLADDER CARCINOMA NON-MUSCLE INVASIVE BLADDER CARCINOMA

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

NON MUSCLE INVASIVE BLADDER CANCER